Keri Donaldson

Keri Donaldson is a distinguished professional with extensive experience in clinical pathology and healthcare leadership. Currently serving as Vice Chair of Clinical Pathology at Geisinger since June 2023, Keri has also been the Chief Executive Officer and Founder of SOLVD Health since October 2013. Keri held the position of Director at Penn State Hershey IPM Clinical Genomics from January 2015 to July 2023 and previously served as Medical Director of Hematology and Thrombosis, as well as Medical Director of Molecular Diagnostics at Penn State Milton S. Hershey Medical Center from July 2011 to December 2015. Keri's educational background includes a Master of Science in Clinical Epidemiology from the University of Pennsylvania School of Medicine, a Doctor of Medicine from Temple University, and a Pre-Medicine degree from Penn State University.